|
Volumn 21, Issue 5, 2013, Pages 1097-1108
|
Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linker
|
Author keywords
1,3 Dipolar cycloaddition; Antiviral; Cytostatic; Isoxazolidines; Phosphonates
|
Indexed keywords
5 ARYLCARBAMOYL 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2 ACETYLPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2 BROMOPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2 CHLOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2 FLUOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2 NITROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (2,4 DIFLUOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 ACETYLPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 BROMOPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 CHLOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 CYANOPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 FLUOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 NITROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (3 TOLYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 ACETYLPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 BROMOPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 CHLOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 CYANOPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 FLUOROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
DIETHYL 5 (4 NITROPHENYLCARBAMOYL) 2 METHYLISOXAZOLIDIN 3 YL 3 PHOSPHONIC ACID;
ISOXAZOLIDINE DERIVATIVE;
ISOXAZOLIDINE PHOSPHONIC ACID;
N (2 ACETHYL 4,5 DIMETHOXYPHENYL)ACRYLAMIDE;
N (2 CYANO 4,5 DIMETHOXYPHENYL)ACRYLAMIDE;
N (2,4 DIFLUOROPHENYL)ACRYLAMIDE;
N (3 CYANOPHENYL)ACRYLAMIDE;
N (3 FLUOROPHENYL)ACRYLAMIDE;
N ARYLACRYLAMIDE;
N METHYL DIETHOXYPHOSPHORYLNITRONE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL CELL;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL PROLIFERATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CORONAVIRUS;
COXSACKIE VIRUS B4;
CYTOSTASIS;
DNA VIRUS;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG DNA INTERACTION;
DRUG SCREENING;
DRUG SYNTHESIS;
HERPES SIMPLEX VIRUS 1;
HERPES SIMPLEX VIRUS 2;
HERPES VIRUS;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HYDROGEN BOND;
IC 50;
INFLUENZA VIRUS A H1N1;
INFLUENZA VIRUS A H3N2;
INFLUENZA VIRUS B;
MAMMALIAN ORTHOREOVIRUS;
NONHUMAN;
PARAINFLUENZA VIRUS 3;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RNA VIRUS;
SINDBIS VIRUS;
STRUCTURE ACTIVITY RELATION;
SUBSTITUTION REACTION;
TOROVIRUS;
VACCINIA VIRUS;
VESICULAR STOMATITIS VIRUS;
ANTIVIRAL AGENTS;
CARBAMATES;
CELL LINE;
CELL PROLIFERATION;
CYTOSTATIC AGENTS;
DNA VIRUSES;
DRUG DESIGN;
HELA CELLS;
HUMANS;
ISOXAZOLES;
NUCLEOTIDES;
RNA VIRUSES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
RNA VIRUSES;
|
EID: 84873707302
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.01.007 Document Type: Article |
Times cited : (21)
|
References (40)
|